Back to Search
ANDY WILLIS, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1043695505Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Control of periplasmic interdomain thiol:disulfide exchange in the transmembrane oxidoreductase DsbD.
PMID 19004826·J Biol Chem·2009
8-other
The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity.
PMID 18505918·Mol Cancer Res·2008
8-other
Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies.
PMID 17525953·Head Neck·2007
8-other
An online novel adaptive filter for denoising time series measurements.
PMID 16649562·ISA Trans·2006
8-other
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
PMID 14743206·Oncogene·2004
8-other
p73 can suppress the proliferation of cells that express mutant p53.
PMID 12934108·Oncogene·2003
8-other
The promise and obstacle of p53 as a cancer therapeutic agent.
PMID 12108946·Curr Mol Med·2002
6-review
Effects of topical administration of 0.005% latanoprost solution on eyes of clinically normal horses.
PMID 11763186·Am J Vet Res·2001
7-preclinical
Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses.
PMID 11341390·Am J Vet Res·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 139 E MAIN ST
FOREST CITY, NC 28043 - Phone
- (828) 245-4591
Quick Facts
- NPI
- 1043695505
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile